An essential contribution by IFN-γ to CD8+ T cell-mediated rejection of pancreatic islet allografts

被引:79
作者
Diamond, AS
Gill, RG
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Dept Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Dept Immunol, Denver, CO 80262 USA
关键词
D O I
10.4049/jimmunol.165.1.247
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T cells have long been considered to be the prototypical cytotoxic lymphocyte subpopulation. However, whether alloreactive CD8(+) T cells require traditional cytolytic pathways such as perforin and Fas ligand (FasL) to mediate graft rejection has been a controversial issue. In the present studies, we examined the role of varied effector pathways in CD8(+) T cell-mediated rejection of pancreatic islet allografts, Our goal was to systematically determine the relative requirements, if any, of perforin and Fast as well as the proinflammatory cytokine IFN-gamma in triggering graft destruction. To study CDS' T cell effector pathways independently of other lymphocyte populations, purified alloreactive CD8(+) T cells were adoptively transferred into severe combined immune-deficient (SCID) recipients bearing established islet allografts, Results indicate that to reject established islet allografts, primed CD8(+) T cells do not require the individual action of the conventional cytotoxic effecters perforin and Fas ligand, In contrast, the ability to produce IFN-gamma is critical for efficient CD8(+) T cell-mediated rejection of established islet allografts, Furthermore, alloreactive CD8(+) TCR transgenic T cells (2C) also show IFN-gamma dependence for mediating islet allograft rejection in vivo. We speculate from these results that the production of IFN-gamma by alloreactive CD8(+) T cells is a rate-limiting step in the process of islet allograft rejection.
引用
收藏
页码:247 / 255
页数:9
相关论文
共 62 条
[41]  
Sad S, 1997, J IMMUNOL, V159, P606
[42]   CYTOKINE-INDUCED DIFFERENTIATION OF PRECURSOR MOUSE CD8(+) T-CELLS INTO CYTOTOXIC CD8(+) T-CELLS SECRETING TH1 OR TH2 CYTOKINES [J].
SAD, S ;
MARCOTTE, R ;
MOSMANN, TR .
IMMUNITY, 1995, 2 (03) :271-279
[43]   Acute rejection of vascularized heart allografts in the absence of IFN gamma [J].
Saleem, S ;
Konieczny, BT ;
Lowry, RP ;
Baddoura, FK ;
Lakkis, FG .
TRANSPLANTATION, 1996, 62 (12) :1908-1911
[44]   USE OF FICOLL IN PREPARATION OF VIABLE ISLETS OF LANGERHANS FROM RAT PANCREAS [J].
SCHARP, DW ;
KEMP, CB ;
KNIGHT, MJ ;
BALLINGE.WF ;
LACY, PE .
TRANSPLANTATION, 1973, 16 (06) :686-689
[45]  
SEDER RA, 1992, J IMMUNOL, V148, P1652
[46]   THE PRESENCE OF INTERLEUKIN-4 DURING INVITRO PRIMING DETERMINES THE LYMPHOKINE-PRODUCING POTENTIAL OF CD4+ T-CELLS FROM T-CELL RECEPTOR TRANSGENIC MICE [J].
SEDER, RA ;
PAUL, WE ;
DAVIS, MM ;
FAZEKAS DE ST GROTH, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1091-1098
[47]  
Sedger LM, 1999, J IMMUNOL, V163, P920
[48]   Contribution of Fas ligand to cardiac allograft rejection [J].
Seino, K ;
Kayagaki, N ;
Bashuda, H ;
Okumura, K ;
Yagita, H .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (09) :1347-1354
[49]   SELECTIVE EXPRESSION OF AN ANTIGEN RECEPTOR ON CD8-BEARING LYMPHOCYTES-T IN TRANSGENIC MICE [J].
SHA, WC ;
NELSON, CA ;
NEWBERRY, RD ;
KRANZ, DM ;
RUSSELL, JH ;
LOH, DY .
NATURE, 1988, 335 (6187) :271-274
[50]   ACUTE REJECTION OF VASCULAR HEART ALLOGRAFTS BY PERFORIN-DEFICIENT MICE [J].
SHULZ, M ;
SCHUURMAN, HJ ;
JOERGENSEN, J ;
STEINER, C ;
MEERLOO, T ;
KAGI, D ;
HENGARTNER, H ;
SCHREIER, MH ;
BURKI, K ;
LEDERMANN, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (02) :474-480